MedTrace Logo

Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding

NCT01659008 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-02-16

No results posted yet for this study

Summary

Treatment with Estradiol is non-inferior to treatment with Tranexamic acid in reducing the amount and duration of menstrual blood loss in women with cyclic heavy menstrual bleeding

Conditions

  • Menstrual Cycle and Uterine Bleeding Disorders

Interventions

DRUG

Estradiol

DRUG

Lysteda

Sponsors & Collaborators

  • American College of Obstetricians and Gynecologists

    collaborator OTHER

  • Kay I Waud MD PhD

    lead OTHER

Principal Investigators

  • Kay I Waud, MD PhD · Eastern Virginia Medical School department of obstetrics and gynecology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-12-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01659008 on ClinicalTrials.gov